Business · 21/12/2009
FDA Approves Injectable Dosage Form for Polysulfated Glycosaminoglycan
The FDA is updating its regulations to reflect the approval of a new dosage form for polysulfated glycosaminoglycan, a treatment for which Luitpold Pharmaceuticals has submitted a supplemental application, allowing for larger vial sizes of the injectable solution.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →